title: Characterization of bacterial DNA binding to human neutrophil surface.
abstract: Bacterial DNA activates neutrophils through a CpG- and TLR9-independent mechanism. Neutrophil activation does not require DNA internalization, suggesting that it results from the interaction of bacterial DNA with a neutrophil surface receptor. The aim of this study was to characterize the interaction of bacterial DNA with the neutrophil surface. Bacterial DNA binding showed saturation and was inhibited by unlabeled DNA but not by other polyanions like yeast tRNA and poly-A. Resembling the conditions under which bacterial DNA triggers neutrophil activation, binding was not modified in the presence or absence of calcium, magnesium or serum. Treatment of neutrophils with proteases not only dramatically reduced bacterial DNA binding but also inhibited neutrophil activation induced by bacterial DNA. Experiments performed with DNA samples of different lengths obtained after digestion of bacterial DNA with DNase showed that only DNA fragments greater than approximately 170-180 nucleotides competed bacterial DNA binding and retained the ability to trigger cell activation. Treatment of neutrophils with chemoattractants or conventional agonists significantly increased bacterial DNA binding. Moreover, neutrophils that underwent transmigration through human endothelial cell monolayers even in the absence of chemoattractants, exhibited higher binding levels of bacterial DNA. Together, our findings provide evidence that binding of bacterial DNA to neutrophils is a receptor-mediated process that conditions the ability of DNA to trigger cell activation. We speculate that neutrophil recognition of bacterial DNA might be modulated by the balance of agonists present at inflammatory foci. This effect might be relevant in bacterial infections with a biofilm etiology, in which extracellular DNA could function as a potent neutrophil agonist.
authors.affiliation: Departamento de Inmunología, Instituto de Investigaciones Hematológicas and Instituto de Estudios Oncológicos 'Fundación Maissa', Academia Nacional de Medicina, Buenos Aires, Argentina.
authors.forename: Juan I
authors.initials: JI
authors.lastname: Fuxman Bass
authors.forename: Maria L
authors.initials: ML
authors.lastname: Gabelloni
authors.forename: María E
authors.initials: ME
authors.lastname: Alvarez
authors.forename: Mónica E
authors.initials: ME
authors.lastname: Vermeulen
authors.forename: Daniela M
authors.initials: DM
authors.lastname: Russo
authors.forename: Angeles
authors.initials: A
authors.lastname: Zorreguieta
authors.forename: Jorge R
authors.initials: JR
authors.lastname: Geffner
authors.forename: Analía S
authors.initials: AS
authors.lastname: Trevani
mesh_terms: D001483:Base Sequence; D018441:Biofilms; D002478:Cells, Cultured; D017931:DNA Primers; D004269:DNA, Bacterial / Q000378:metabolism*; D004926:Escherichia coli / Q000235:genetics; D006801:Humans; D009504:Neutrophils / Q000378:metabolism*
chemical_list: D017931:DNA Primers; D004269:DNA, Bacterial